Frequently Asked Questions
The major market drivers for Keratolytic Agents Market are the rising Incidence of Acne.
The major players operating in the Keratolytic Agents Market are Pfizer Inc. (U.S.), GSK plc (UK), Novartis AG (Switzerland), Mylan N.V. (U.S.), Boehringer Ingelheim International GmbH. (Germany), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Bayer AG (Germany), Merck & Co., Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Cadila Pharmaceuticals (India), Lilly (U.S.), LEO Pharma A/S (Denmark), Cipla Inc. (U.S.), Aurobindo Pharma (India), Lupin (India), Sumitomo Corporation (Japan), Taro Pharmaceutical Industries Ltd. (U.S.).
Indication (Psoriasis, Dry Skin, Acne Vulgaris, Warts, Dandruff, Others), Dosage Form (Shampoo, Gel, Solution, Face Wash, Lotion, Creams, Others), Agents (Urea, Salicylic Acid, Lactic Acid, Alpha Hydroxy Acids, Propylene Glycol, Others), Route of Administration (Topical, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) are covered in this report.
The major countries covered in the Keratolytic Agents Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
